This inventor holds 6 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Cardix Therapeutics, LLC. Active years: 2020-2025.
Company Filing History:
Years Active: 2020-2025
Title: Innovations of Ting N Lin in Cardiovascular Treatments
Introduction
Ting N Lin is a notable inventor based in Bengbu, China, recognized for his contributions to the field of pharmaceuticals, particularly in the treatment of cardiovascular diseases. With a total of five patents to his name, Lin has made significant strides in developing innovative pharmaceutical compositions.
Latest Patents
Among his latest patents, Lin has focused on pharmaceutical compositions and methods for treating cardiovascular diseases. His work includes a composition that comprises two or more compounds, each of which can be a phosphodiesterase inhibitor, an adenosine receptor antagonist, a calcium channel blocker, a histamine H-receptor agonist, a histamine H-receptor antagonist, or a β-adrenoreceptor agonist. The methods he has developed aim to treat, prevent, or ameliorate cardiovascular diseases by administering these compounds to subjects in need.
Career Highlights
Throughout his career, Ting N Lin has worked with various companies, including Cardix Therapeutics, LLC and Spacemed-x LLC. His innovative approaches have positioned him as a key figure in the pharmaceutical industry, particularly in the realm of cardiovascular health.
Collaborations
Lin has collaborated with notable professionals in his field, including Jin Jean Wang and Gerald J Yakatan. These partnerships have further enhanced his research and development efforts.
Conclusion
Ting N Lin's contributions to pharmaceutical innovations, especially in cardiovascular treatments, highlight his role as a significant inventor in the industry. His work continues to pave the way for advancements in medical therapies.